Status:
COMPLETED
Single-step Transepithelial PRK for Hyperopia
Lead Sponsor:
Assiut University
Conditions:
Moderate Hyperopia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hyperopia is one of the commonest refractive errors encountered in ophthalmology practice. Laser in situ keratomileusis (LASIK) has been widely used to correct hyperopia especially with the advent of...
Detailed Description
Although the initial refractive results of conventional manual or alcohol assisted PRK for hyperopia were encouraging, the frequently encountered post-PRK complications including undercorrection, over...
Eligibility Criteria
Inclusion
- Patients with moderate hyperopia with a hyperopic cycloplegic spherical equivalent between +2 and + 4.5 diopters D.
- A steep keratometry (Ks) ≤ 46 D.
- Minimum pachymetry of 500 μm with a calculated residual stromal bed exceeding 350 μm after epithelial and stromal ablation.
Exclusion
- Patients not candidate for corneal refractive surgery,
- Steep cornea (Ks \> 46 D) with an expected postoperative keratometry \> 48 D,
- Large angle kappa as estimated by Chord mu \> 0.25 mm,
- Hyperopic amblyopia whether unilateral or bilateral with CDVA less than 0.2 . logMAR acuity,
- Recent contact lens wear, dry eye disease and autoimmune disorders.
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05261685
Start Date
December 1 2019
End Date
December 15 2021
Last Update
July 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TIBA eye center
Asyut, Egypt, 71516